Related Experiment Videos
Clinical toxicity of the interferons
1Laboratoire d'Immunotoxicologie Fondamentale et Clinique, INSERM U80, Faculté de Médecine A. Carrel, Lyon, France.
Drug Safety
|February 1, 1994
Summary
Interferons (IFNs) treat diseases but can cause acute flu-like symptoms and chronic neurological issues. Autoimmune reactions and organ toxicities are rare but require monitoring for patient safety.
Area of Science:
- Immunology
- Pharmacology
- Neurology
Background:
- Interferons (IFNs) are widely used therapeutics with a known side effect profile.
- Adverse effects range from acute, manageable symptoms to chronic, potentially debilitating conditions.
Purpose of the Study:
- To comprehensively review the adverse effects associated with interferon therapy.
- To inform clinicians and patients about the spectrum of potential toxicities and their management.
Main Methods:
- Literature review of reported adverse events associated with interferon treatment.
- Analysis of the timing, frequency, and severity of various toxicities.
Main Results:
- Acute effects include flu-like symptoms, cardiovascular changes, and gastrointestinal issues.
- Chronic effects encompass neurological toxicity (fatigue, cognitive changes), rare autoimmune disorders (thyroiditis, lupus-like syndromes), and organ-specific toxicities (hepatotoxicity, nephrotoxicity, hematotoxicity).
- Cutaneous reactions and injection site issues are also reported.
Conclusions:
- While IFNs are effective treatments, a thorough understanding of their adverse effects is crucial.
- Monitoring for both acute and chronic toxicities, particularly neurological and autoimmune complications, is essential for patient management and treatment adherence.